• Study of Abemaciclib and Giredestrant for Patients with Early Stage ER-Positive, HER2-Negative Breast Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy

  • Study on the Safety of Lutetium (177Lu) Oxodotreotide with Arginine and Lysine in Children with Refractory or Recurrent Neuroblastoma

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France

  • Study on Rimegepant for Preventing Migraines in Adults with Poor Response to Oral Preventive Medications

    Not recruiting

    3 1 1
    Investigated Drugs:
    Austria Belgium Denmark Finland Germany Italy +3

  • Study on Personalized Linezolid Dosing for Patients with Sepsis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain

  • Study on ABBV-400 with Fluorouracil, Folinic Acid, and Bevacizumab for Adults with Unresectable Metastatic Colorectal Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Germany Spain

  • Study on Early Treatment with Teclistamab and Talquetamab for Patients with Newly Diagnosed High-Risk Multiple Myeloma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain

  • Study on Headache Effects of Sildenafil and Placebo in Men and Women with Episodic Migraine Without Aura

    Not recruiting

    1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark

  • Study on the Safety and Effects of OMS906 for Patients with C3 Glomerulopathy and Idiopathic Immune Complex-Mediated Glomerulonephritis

    Not recruiting

    2 1 1
    Investigated Drugs:
    Lithuania Poland

  • Comparison of Atropine 0.

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands

  • Title: Study of gene therapy Etranacogene Dezaparvovec (Hemgenix) in adult patients with moderate to severe Hemophilia B

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Denmark Germany Ireland The Netherlands Sweden

powered by